Skip to main content
SpringerLink
Log in

Bessere Lebensqualität mit Crizotinib

  • Journal Club
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Blackhall F, Kim DW, Besse B et al (2014) Patient-reported outcomes and quality of life in PROFILE 1007: a randomized trial of crizotinib compared with chemotherapy in previously treated patients with ALK-positive advanced non-small-cell lung cancer. J Thorac Oncol 9(11):1625–1633

    Article  CAS  PubMed  Google Scholar 

  2. Shaw AT, Kim DW, Nakagawa K et al (2013) Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368(25):2385–2394

    Article  CAS  PubMed  Google Scholar 

  3. Solomon BJ, Mok T, Kim DW et al (2014) PROFILE 1014 Investigators. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med 371(23):2167–2177

    Article  CAS  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. N. Reinmuth erhielt Honoraria für Vorträge von Hoffmann-La Roche, Lilly, Novartis, Boehringer-Ingelheim, TEVA, Otsuka, MSD und Bristol-Myers Squibb und für Beratungen von Hoffmann-La Roche, Lilly, Amgen, Novartis, MSD und Bristol-Myers Squibb.

Author information

Authors and Affiliations

  1. Abteilung für Thorakale Onkologie, LungenClinic Großhansdorf, Airway Research Center North, Mitglied des Deutschen Zentrums für Lungenforschung (DZL), Wöhrendamm 80, 22927, Großhansdorf, Deutschland

    N. Reinmuth

Authors
  1. N. Reinmuth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Reinmuth.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reinmuth, N. Bessere Lebensqualität mit Crizotinib. Onkologe 21, 637–638 (2015). https://doi.org/10.1007/s00761-015-2975-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-015-2975-4

Search

Navigation